TWD
NVCT icon

True Wealth Design’s Nuvectis Pharma NVCT Stock Holding History

True Wealth Design’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74 Buy
+4
New +$45 ﹤0.01% 2570

Other funds holding NVCT

BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

True Wealth Design's NVCT Position: Q2 2026 in Review

True Wealth Design opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 4 shares worth $74. The stake represents ﹤0.01% of the portfolio and ranks #2570 among its holdings.

7 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • True Wealth Design held 4 shares of Nuvectis Pharma worth $74 as of Q2 2026.
  • Nuvectis Pharma was a new True Wealth Design position in Q2 2026.
  • Nuvectis Pharma made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2570 holding.
  • 7 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.